The Net Zero Barometer 2026: Healthcare and Pharma Sector Insights

Learn how healthcare and pharma are tackling sustainability goals while ensuring patient safety and managing complex supply chains.

What do Healthcare and Pharmaceuticals tell us about net zero transition?

Explore the data behind two distinct pathways, from pharma supply chains to healthcare costs and procurement.

92% of pharma firms are concerned about future costs and resilience, versus 80% overall.
96% of pharma firms trust their emissions data, with supply chain confidence reaching 93%.
89% of pharma firms have changed climate communications, the highest of any sector.
46% of healthcare and medical device firms cite cost as their main barrier to net zero.
36% of healthcare firms say cost savings and operational efficiency are driving action.
48% of medical devices used in the UK are single-use, creating a major circularity challenge.